Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau.

about

Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau.

Item

http://www.wikidata.org/entity/Q47739900

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characterization of the radios ...... igand for neurofibrillary tau.

@en

Characterization of the radios ...... igand for neurofibrillary tau.

@nl

type

Item

label

Characterization of the radios ...... igand for neurofibrillary tau.

@en

Characterization of the radios ...... igand for neurofibrillary tau.

@nl

prefLabel

Characterization of the radios ...... igand for neurofibrillary tau.

@en

Characterization of the radios ...... igand for neurofibrillary tau.

@nl

P1476

Characterization of the radios ...... igand for neurofibrillary tau.

@en

P2093

Bradley T Christian

http://www.w3.org/2001/XMLSchema#string

Dhanabalan Murali

http://www.w3.org/2001/XMLSchema#string

Jonathan W Engle

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Okamura

http://www.w3.org/2001/XMLSchema#string

Patrick J Lao

http://www.w3.org/2001/XMLSchema#string

Paul A Ellison

http://www.w3.org/2001/XMLSchema#string

Robert J Nickles

http://www.w3.org/2001/XMLSchema#string

Shozo Furumoto

http://www.w3.org/2001/XMLSchema#string

Sterling C Johnson

http://www.w3.org/2001/XMLSchema#string

Todd E Barnhart

http://www.w3.org/2001/XMLSchema#string

P2860

ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers.

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification.

Tau positron emission tomographic imaging in aging and early Alzheimer disease

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

Defining imaging biomarker cut points for brain aging and Alzheimer's disease.

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.

Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy.

Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

P304

230-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.APRADISO.2017.10.002

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Tobey J Betthauser

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29031087

http://www.w3.org/2001/XMLSchema#string

P932

5673567

http://www.w3.org/2001/XMLSchema#string